News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,142 Results
Type
Article (43689)
Company Profile (289)
Press Release (692154)
Multimedia
Podcasts (85)
Webinars (17)
Section
Business (208041)
Career Advice (2188)
Deals (36311)
Drug Delivery (115)
Drug Development (83355)
Employer Resources (176)
FDA (16677)
Job Trends (15218)
News (353032)
Policy (33461)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2688)
Accelerated approval (32)
Adcomms (27)
Allergies (144)
Alliances (50709)
ALS (172)
Alzheimer's disease (1698)
Antibody-drug conjugate (ADC) (312)
Approvals (16918)
Artificial intelligence (510)
Autoimmune disease (150)
Automation (37)
Bankruptcy (367)
Best Places to Work (11820)
BIOSECURE Act (21)
Biosimilars (187)
Biotechnology (191)
Bladder cancer (160)
Brain cancer (59)
Breast cancer (639)
Cancer (4849)
Cardiovascular disease (402)
Career advice (1849)
Career pathing (35)
CAR-T (281)
CDC (47)
Celiac Disease (2)
Cell therapy (745)
Cervical cancer (36)
Clinical research (71117)
Collaboration (1705)
Company closure (4)
Compensation (1140)
Complete response letters (71)
COVID-19 (2777)
CRISPR (93)
C-suite (833)
Cystic fibrosis (144)
Data (6202)
Decentralized trials (2)
Denatured (26)
Depression (132)
Diabetes (503)
Diagnostics (6812)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (246)
Drug pricing (188)
Drug shortages (29)
Duchenne muscular dystrophy (226)
Earnings (90835)
Editorial (56)
Employer branding (21)
Employer resources (153)
Events (118825)
Executive appointments (973)
FDA (19790)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1480)
Gene editing (204)
Generative AI (43)
Gene therapy (601)
GLP-1 (988)
Government (4768)
Grass and pollen (8)
Guidances (383)
Healthcare (19307)
HIV (55)
Huntington's disease (45)
IgA nephropathy (81)
Immunology and inflammation (259)
Immuno-oncology (56)
Indications (103)
Infectious disease (3035)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (244)
Interviews (358)
IPO (16862)
IRA (50)
Job creations (3741)
Job search strategy (1544)
JPM (56)
Kidney cancer (15)
Labor market (85)
Layoffs (579)
Leadership (31)
Legal (8039)
Liver cancer (94)
Longevity (14)
Lung cancer (654)
Lymphoma (378)
Machine learning (43)
Management (59)
Manufacturing (796)
MASH (165)
Medical device (14055)
Medtech (14109)
Mergers & acquisitions (20525)
Metabolic disorders (1276)
Multiple sclerosis (159)
NASH (17)
Neurodegenerative disease (317)
Neuropsychiatric disorders (87)
Neuroscience (2934)
Neurotech (1)
NextGen: Class of 2026 (6715)
Non-profit (4599)
Now hiring (65)
Obesity (600)
Opinion (269)
Ovarian cancer (166)
Pain (197)
Pancreatic cancer (226)
Parkinson's disease (284)
Partnered (33)
Patents (489)
Patient recruitment (480)
Peanut (57)
People (59816)
Pharmaceutical (64)
Pharmacy benefit managers (29)
Phase 1 (22206)
Phase 2 (31311)
Phase 3 (23298)
Pipeline (5119)
Policy (284)
Postmarket research (2609)
Preclinical (9362)
Press Release (66)
Prostate cancer (237)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (844)
Real estate (6150)
Recruiting (71)
Regulatory (25047)
Reports (52)
Research institute (2479)
Resumes & cover letters (371)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (151)
Series A (246)
Series B (190)
Service/supplier (11)
Sickle cell disease (100)
Special edition (23)
Spinal muscular atrophy (159)
Sponsored (42)
Startups (3746)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (86)
The Weekly (57)
Vaccines (1001)
Venture capital (92)
Weight loss (391)
Women's health (88)
Worklife (18)
Date
Today (2)
Last 7 days (604)
Last 30 days (2132)
Last 365 days (30233)
2026 (2870)
2025 (30647)
2024 (35740)
2023 (40668)
2022 (51841)
2021 (56390)
2020 (54860)
2019 (47550)
2018 (35881)
2017 (32941)
2016 (32373)
2015 (38381)
2014 (32072)
2013 (27078)
2012 (29265)
2011 (29912)
2010 (28001)
Location
Africa (778)
Alabama (83)
Alaska (7)
Arizona (307)
Arkansas (13)
Asia (40815)
Australia (6712)
California (11240)
Canada (3266)
China (1110)
Colorado (471)
Connecticut (478)
Delaware (333)
Europe (88292)
Florida (1664)
Georgia (357)
Hawaii (3)
Idaho (62)
Illinois (867)
India (63)
Indiana (516)
Iowa (23)
Japan (419)
Kansas (128)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1391)
Massachusetts (8131)
Michigan (322)
Minnesota (627)
Mississippi (5)
Missouri (126)
Montana (34)
Nebraska (28)
Nevada (121)
New Hampshire (80)
New Jersey (2977)
New Mexico (29)
New York (2972)
North Carolina (1466)
North Dakota (10)
Northern California (5459)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2273)
Puerto Rico (22)
Rhode Island (47)
South America (1151)
South Carolina (66)
South Dakota (1)
Southern California (4381)
Tennessee (173)
Texas (1741)
United States (39979)
Utah (338)
Vermont (1)
Virginia (261)
Washington D.C. (81)
Washington State (918)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
736,142 Results for "complete genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Repare Announces Completion of Acquisition by XenoTherapeutics, Inc.
January 29, 2026
·
6 min read
Press Releases
Complete Genomics Highlights Clinical Research Sequencing Solutions and Partnerships at AMP 2025
November 11, 2025
·
5 min read
Press Releases
PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring
January 5, 2026
·
10 min read
Press Releases
OCHRE BIO COMPLETES HUMAN LIVER FUNCTIONAL GENOMICS AND SINGLE-CELL DATASETS IN PARTNERSHIP WITH GSK
November 18, 2025
·
2 min read
Press Releases
Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG
October 14, 2025
·
2 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025
October 15, 2025
·
5 min read
Press Releases
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025
November 11, 2025
·
5 min read
Press Releases
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
September 18, 2025
·
6 min read
Press Releases
Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma
December 4, 2025
·
4 min read
1 of 73,615
Next
